Next Article in Journal
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up
Next Article in Special Issue
New Approaches to the Prevention of Visceral Leishmaniasis: A Review of Recent Patents of Potential Candidates for a Chimeric Protein Vaccine
Previous Article in Journal
Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine
Previous Article in Special Issue
Evaluation of a Vaccine Candidate Designed for Broad-Spectrum Protection against Type A Foot-and-Mouth Disease in Asia
 
 
Article

Article Versions Notes

Vaccines 2024, 12(2), 139; https://doi.org/10.3390/vaccines12020139
Action Date Notes Link
article xml file uploaded 29 January 2024 10:21 CET Original file -
article xml uploaded. 29 January 2024 10:21 CET Update https://www.mdpi.com/2076-393X/12/2/139/xml
article pdf uploaded. 29 January 2024 10:21 CET Version of Record https://www.mdpi.com/2076-393X/12/2/139/pdf
article supplementary file uploaded. 29 January 2024 10:21 CET - https://www.mdpi.com/2076-393X/12/2/139#supplementary
article html file updated 29 January 2024 10:23 CET Original file https://www.mdpi.com/2076-393X/12/2/139/html
Back to TopTop